Enterprise Therapeutics

Description: Enterprise Therapeutics develops respiratory medicines for cystic fibrosis, asthma & COPD, targeting mucus congestion to improve patient outcomes.

Country: UK

Based in: Falmer

Founded: 2014

Funding Stage: Series A/B

Tags: ['Health Care', 'Health Diagnostics', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.